DZ Bank has significantly reduced its holdings in Regeneron Pharmaceuticals, offloading 74.4% of its shares in Q4. Despite ...

Representative Robert Bresnahan Jr. recently waved goodbye to his Regeneron Pharmaceuticals shares, sparking curiosity over ...

Real-time index price for TSX Composite High Dividend Index (TXEI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...

In a longer-term context, Regeneron's total shareholder return, including dividends, was a decline of 8.37% over the past five years. This performance trails the past year's market return of 8% and ...

We recently compiled a list of the 10 Jim Cramer Stocks with Huge Upside Potential. In this article, we are going to take a ...

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past ...

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.

When a stock falls steadily on no news, that is a hint to avoid the company. Organon (OGN), a spin-off from Merck (MRK), continued to trade at a discount after posting results. The firm cut its ...

Regeneron Pharmaceuticals currently returns an annual dividend yield of 0.2%. The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It ...

In today's video, I am going to look at four dividend stocks that appear cheap based on valuation. One of those stock picks is NextEra Energy (NYSE: NEE), a favorite of mine. Where to invest $1,000 ...

Shares of Regeneron Pharmaceuticals are trading higher Wednesday recovering after a drop on Tuesday that followed the release of weaker-than-expected first quarter 2025 financial results.